# A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects

> **NCT01104532** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 64 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of ASP1941

## Interventions

- **DRUG:** ASP1941
- **DRUG:** sitagliptin

## Key facts

- **NCT ID:** NCT01104532
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2010-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104532, "A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01104532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*